Isotechnika Pharma Inc IPHAF

RE: Does Paladin still hold rights to ISA IP in th

[MementoMori]

Paladin does still hold the Canadian rights to Voclera but they seem to disinclined to do much about it...in their 2011 annual report they wrote that "Given the estimated costs to further advance the regulatory submission for voclosporin for the treatment of psoriasis in the Canadian marketplace, the Company decided to withdraw its New Drug Submission (NDS) [for psoriasis] at Health Canada." (p. 16)

However, the next sentence does state that: "The Company, through its agreement with IsoPharma continues to advance the clinical development program for Voclera (voclosporin) as an immunosuppressant in transplant patients."